SolskinInvestment Thesis Teladoc (NYSE:TDOC) is set to report its Q2 2024 results next week, Wednesday, after hours. Having been bearish on Teladoc stock for some time, I now no longer believe it makes sense to sustain this bearish outlook. Even as I recognize that Teladoc today operates as a shadow of its former self, I nevertheless contend that this insight has already been priced into its stock. At approximately 5x next year's free cash flow, there is a better risk-reward than there's been in quite s ...